AMERISOURCEBERGEN CORP (ABC) [Rocket]

In millions, except per share items	Sep-30-22	Sep-30-21	Sep-30-20	Sep-30-19	Sep-30-18	Sep-30-17	Sep-30-16	Sep-30-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues:
Pharmaceutical Distribution				172,813.5	161,699.3	147,453.5	141,702.0	132,383.8
Other				6,868.3	6,332.7	5,747.9	5,207.1	3,586.9
Total revenues	238,587.0	213,988.8	189,893.9	179,589.1	167,939.6	153,143.8	146,849.7	135,961.8
Revenue growth [+]	11.5%	12.7%	5.7%	6.9%	9.7%	4.3%	8.0%	13.7%
Pharmaceutical Distribution				6.9%	9.7%	4.1%	7.0%	12.8%
Other				8.5%	10.2%	10.4%	45.2%	46.5%
Cost of goods sold	230,290.6	207,045.6	184,702.0	174,450.8	163,327.3	148,597.8	142,577.1	132,432.5
Gross profit	8,296.4	6,943.2	5,191.9	5,138.3	4,612.3	4,546.0	4,272.6	3,529.3
Gross margin	3.5%	3.2%	2.7%	2.9%	2.7%	3.0%	2.9%	2.6%
Selling, general and administrative	4,849.0	3,594.3	2,767.2	2,663.5	2,460.3	2,128.7	2,091.2	1,907.8
Other operating expenses	183.1	199.3	85.0				187.9	912.7
EBITDA [+]	3,280.3	3,159.3	2,356.7	2,509.9	2,197.0	2,452.0	2,020.9	716.1
EBITDA growth	3.8%	34.1%	-6.1%	14.2%	-10.4%	21.3%	182.2%	-29.2%
EBITDA margin	1.4%	1.5%	1.2%	1.4%	1.3%	1.6%	1.4%	0.5%
Depreciation	390.6	326.7	290.7	321.1	318.5	262.4	232.5	193.3
EBITA	2,889.6	2,832.6	2,065.9	2,188.8	1,878.5	2,189.6	1,788.3	522.8
EBITA margin	1.2%	1.3%	1.1%	1.2%	1.1%	1.4%	1.2%	0.4%
Amortization of intangibles	319.2	188.1	117.3	176.4	191.6	169.9	159.6	62.7
EBIT [+]	2,570.5	2,644.5	1,948.6	2,012.4	1,686.9	2,019.7	1,628.7	460.1
EBIT growth	-2.8%	35.7%	-3.2%	19.3%	-16.5%	24.0%	254.0%	-43.5%
EBIT margin	1.1%	1.2%	1.0%	1.1%	1.0%	1.3%	1.1%	0.3%
Non-recurring items [+]	204.1	290.3	7,084.0	900.5	243.2	959.3	102.9	37.9
Asset impairment	80.9	17.7	361.7	570.0	59.7
Interest expense	210.7	174.1	137.9	157.8	174.7	145.2	139.9	91.5
Interest expense	210.7	174.1	137.9	157.8	174.7	145.2	139.9	91.5
Other income (expense), net [+]	27.4	41.7	-20.6	13.0	-91.6	2.7	5.0	-61.8
Gain (loss) on debt retirement			-22.2		-23.8
Other	-27.4	-41.7	-1.6	-13.0	25.5	-2.7
Pre-tax income	2,183.1	2,221.9	-5,293.8	967.1	1,177.4	917.9	1,390.9	269.0
Income taxes	516.5	677.3	-1,894.3	113.0	-438.5	553.4	-37.0	407.1
Tax rate	23.7%	30.5%	35.8%	11.7%		60.3%		151.4%
Minority interest	-32.3	4.7	9.2	-1.2	-42.5
Net income	1,698.8	1,539.9	-3,408.7	855.4	1,658.4	364.5	1,427.9	-138.2
Net margin	0.7%	0.7%	-1.8%	0.5%	1.0%	0.2%	1.0%	-0.1%

Basic EPS [+]	$8.15	$7.48	($16.65)	$4.07	$7.61	$1.67	$6.73	($0.63)
Growth	9.0%	-144.9%	-509.0%	-46.5%	356.1%	-75.2%	-1160.7%	-151.2%
Diluted EPS [+]	$8.04	$7.39	($16.65)	$4.04	$7.53	$1.64	$6.32	($0.63)
Growth	8.9%	-144.4%	-512.2%	-46.4%	357.6%	-74.0%	-1096.1%	-153.0%

Dividends per share [+]	$1.84	$1.76	$1.66	$1.60	$1.52	$1.46	$1.36	$1.16
Growth	4.5%	6.0%	3.7%	5.3%	4.1%	7.4%	17.2%	23.0%

Shares outstanding (basic) [+]	208.5	205.9	204.8	210.2	217.9	218.4	212.2	217.8
Growth	1.2%	0.6%	-2.6%	-3.5%	-0.2%	2.9%	-2.6%	-4.2%
Shares outstanding (diluted) [+]	211.2	208.5	204.8	211.8	220.3	221.6	226.0	217.8
Growth	1.3%	1.8%	-3.3%	-3.9%	-0.6%	-1.9%	3.8%	-7.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.